Although the activation of calcium-independent phospholipase A2 (PLA2) enzymes has been described in the heart, the pathogenetic role of this enzyme(s) in hypoxic cell injury has not been previously examined in any tissue. Therefore, we characterized the time course of activation of calcium-independent PLA2 using both plasmalogen and diacylglycerophospholipid substrates during hypoxia in rabbit proximal tubules and examined whether inhibition of calcium-independent PLA2 activity is associated with a cytoprotective effect. Subjecting rabbit proximal tubules to hypoxia for 5 min resulted in at least a threefold increase in cytosolic calcium-independent PLA2, which was selective for plasmalogen substrates (control 444±69 vs hypoxia 1,675±194 pmol* mg protein-' -min-', n = 5). In contrast, no changes in PLA2 activity were observed in the presence of 4 mM EGTA in the membrane fraction using plasmenylcholine substrates. 20 min of hypoxia resulted in an increase in arachidonate from 3±1 to 28±4 ng/mg protein and lactate dehydrogenase release from 7.5±2% to 38±5%, n = 4.
Introduction
Activation of intracellular phospholipase A2 (PLA2)' has been implicated as an important biochemical mechanism responsible for accelerated phospholipid hydrolysis during renal ischemia (1) (2) (3) (4) (5) . The vast majority of previous studies of the PLA2 1. Abbreviations used in this paper: AA, arachidonic acid; Compound 1, 1-3-(E)-6-(bromomethylene)-(tetrahydro-3-( 1-naphthalenyl)-2H-pyran-2-one; LDH, lactate dehydrogenase; PLA2, phospholipase A2. activated during ischemia or anoxia in the kidney have been based on measurements of PLA2 activity using exogenous diacylglycerophospholipid substrates in the presence of supraphysiological concentrations of calcium (1, 5) . Thus, these studies have focused on the identification of calcium-dependent PLA2 enzymes.
Recently, a novel class of intracellular, calcium-independent, plasmalogen-selective PLA2 enzymes have been characterized in canine myocardium and bovine brain (6) (7) (8) . Plasmalogens represent a distinct subclass of diradylglycero-phospholipids that contain an alkenyl ether (i.e., vinyl ether) covalent linkage at the sn-I position, as compared to the O-acyl ester linkage at the sn-1 position ofdiacylglycerophospholipids (9) . Although plasmalogens are important constituents of kidney cortex membranes (10) (11) , the potential role ofplasmalogens as substrates for PLA2(s) activated during renal ischemia has not been previously examined.
Using diacylglycerophospholipid substrates, we recently described the rapid activation of a novel cytosolic calcium-independent PLA2 enzyme during anoxia in rabbit proximal tubules (4) . At the present time, however, it is not known whether this cytosolic calcium-independent enzyme(s) in the kidney uses plasmalogen as a substrate. Although ischemia-induced activation of a membrane-associated form of plasmalogen-selective PLA2 has been observed in rabbit myocardium (12, 13) , the activation ofcytosolic calcium-independent, plasmalogen-selective PLA2 enzyme (s) in response to hypoxia has not been previously studied in any tissue. In addition, the effect of inhibiting calcium-independent PLA2 on hypoxia-induced cell death has also not been previously examined in any model system of hypoxic injury.
The present study was undertaken to (a) characterize the calcium-independent PLA2 activity in rabbit proximal tubules with regard to substrate preference (plasmalogen versus diacylglycerophospholipid); (b) compare the total activity of PLA2 obtained using plasmalogen and diacylglycerophospholipid substrates in the absence and presence ofcalcium to determine whether the majority of PLA2 activity requires calcium or is calcium-independent; (c) characterize the time course of activation of calcium-independent PLA2 using both plasmalogen and diacylglycerophospholipid substrates during hypoxia in rabbit proximal tubules and compare to the time course of lactate dehydrogenase (LDH) release as a marker of ischemic cell injury; and (d) determine whether inhibition of calciumindependent PLA2 activity is associated with a cytoprotective effect.
Methods
Radioactive lipids were from Du Pont-New England Nuclear Research Products (Boston MA). Cell culture media reagents, Percoll, and fatty acid-free albumin were all obtained from Sigma Chemical Co. (St.
Louis, MO). Compound I (1-3-(E)-6-(bromomethylene)-(tetrahydro-3-( l-naphthalenyl)-2H-pyran-2-one) prepared as previously described ( 14, 15) , was a generous gift of Hoffman-LaRoche Inc. (Nutley, NJ).
Proximal tubule isolation. Rabbit proximal tubules were isolated as previously described (4) and resuspended in DME/F12 medium at a protein concentration of 1.5 mg/ml. Isolated proximal tubules were then transferred from ice to a 370C shaking water bath and preequilibrated for 20 min in a 95% 02/5% CO2 atmosphere. In the experiments using the plasmalogen-selective PLA2 inhibitor (Compound I), proximal tubules were incubated with Compound I for 30 min before starting the experiments. Hypoxia was achieved by subjecting the tubules to a 95% N2/5% CO2 atmosphere that was maintained for variable time periods at 370C. Samples were obtained before hypoxia and at different hypoxic intervals for measurements of cytosolic LDH release.
For the measurement of LDH release, 1 ml of tubule suspension was centrifuged through a 0.4-ml of a mixture ofdibutyl phthalate and dioctyl phthalate (2:1) to separate the tubules from the extracellular medium. LDH activity was measured spectrophotometrically on Triton-permeabilized 0.5 ml oftubule suspensions and corresponding supernatants as previously described ( 16) .
Subcellularfractionation. Tubules subjected to either normoxia or hypoxia were disrupted with 50 strokes ofa Dounce homogenizer in an ice-cold buffer comprised of 50 mM Tris (hydroxymethyl)-aminomethane hydrochloride, 4 mM EGTA, pH 7.3, containing 1% (10 mg/ ml) aprotinin, and 0.1 mM phenylmethylsulfonyl fluoride. After homogenization, nuclei were sedimented at 500 g for 5 min, and the resulting supernatant was centrifuged at 100,000 g for 1 h to obtain membrane (pellet) and cytosolic (supernatant) fractions.
Arachidonic acid (AA) release. AA was measured after a modified method previously described by us (4) . Briefly, AA was extracted from a 2-ml aliquot of the 2 mg/ml tubule suspensions after a Bligh Dyer procedure ( 17) after the addition of20 ng ofoctadeuterated (d8) AA as internal standard. AA isolated on C 18 columns was then converted to the pentafluorobenzoyl ester, evaporated to dryness, and dissolved in acetonitrile for mass spectrometry. The quantity ofAA was determined by high pressure liquid chromatography/particle beam/mass spectrometry in the electron capture negative ion chemical ionization mode and monitoring m/z 303 for arachidonic acid and m/z 31 1 for deuterated AA as previously described (4, 18) .
Phospholipase A2 assays. Phospholipase A2 activity was assayed using synthetic choline diacylglycerophospholipids specifically radiolabeled at the sn-2 position with [3H]oleate acid or [3H]arachidonic acid. I -O-hexadecanoyl-2-cis-octadec- [ 9, 10-3H ] enoyl-sn-glycero-3-phosphocholine (3H-labeled phosphatidylcholine) and l-O-hexadec-1 '-enyl -2-cis-octadec- [9,10-3H ] enoyl-sn-glycero -3-phosphocholine (3H-labeled plasmenylcholine) were prepared by dimethylaminopyridine-catalyzed acylation of l-O-hexadecanoyl-sn-glycero-3-phosphocholine and 1 -O-hexadec-1 '-enyl-sn-glycero-3-phosphocholine, respectively, using [3H]oleic anhydride as previously described (19 ( 17, 20 ofthe total plasmenylcholine mass and < 1% of the total phosphatidylcholine mass present during the assay of cytosolic PLA2 activity. In the assay of membrane-associated PLA2 activity, endogenous choline phospholipids contributed < 5% of the total plasmenylcholine and < 20% of the total phosphatidylcholine mass. Accordingly, measurements of PLA2 activity in the cytosol and membranes are not significantly affected by the presence of endogenous substrate. Table I summarizes the results of our characterization of the substrate specificity, calcium-ion requirements, and subcellular distribution of enzyme activity. The majority of PLA2 activity in proximal tubules is calcium independent and is present in the cytosolic fraction. This calcium-independent cytosolic PLA2 activity displays a distinct preference for plasmalogen substrates. The PLA2 activity defined with substrates containing esterified arachidonic acid was approximately two-to threefold greater than that obtained using substrates containing esterified linoleate for both plasmalogen and diacylglycerophospholipid classes. The PLA2 activity in the cytosol defined using either 3H-labeled phosphatidylcholine or 3H-labeled plasmenylcholine substrates is not affected by the presence of supraphysiologic concentrations of calcium. The membrane fraction also contains substantial amounts ofcalcium-independent PLA2 activity selective for plasmalogen substrates; however, this activity is considerably lower than the activity found in the cytosolic fraction. In addition, in contrast to the cytosolic fraction, the majority of PLA2 activity present in the membrane fraction, which uses choline diacylglycerophospholipid substrates, requires calcium for maximal activity.
Effect ofhypoxia on the activity ofproximal tubule cytosolic plasmalogen-selective PLA2. The effects of hypoxia on PLA2 activity in the cytosolic and membrane fractions in the absence and presence of calcium are shown in Figs. 1 and 2. In Fig. 1 , after a 20-min period ofhypoxia, PLA2 activity was observed to increase more than twofold in the cytosolic fraction. The increase in cytosolic PLA2 activity during hypoxia was demon- During hypoxia in isolated proximal tubules, the increase in cytosolic plasmalogen-selective, calcium-independent PLA2 is time dependent with a rapid and sustained increase in PLA2 activity throughout the 20-min hypoxic interval (Fig 3) . The activation of cytosolic plasmalogen-selective PLA2 is essentially complete within 5 min after the onset of hypoxia. Measurements of PLA2 activity in the presence of 4 mM EGTA in the membrane fraction using plasmenylcholine substrates failed to demonstrate any significant alterations in plasmalogen-selective, calcium-independent PLA2 activity in this fraction throughout the 20-min interval of hypoxia (data not shown).
Effect ofinhibition ofplasmalogen-selective, calcium-independent PLA2 on arachidonic acid release and hypoxia-induced membrane injury. Compound I is a haloenol lactone that belongs to a family of serine esterase inhibitors that have previously been shown to inhibit calcium-independent, plasmalogen-selective PLA2 isolated from canine myocardium. This compound is a mechanism-based, irreversible inhibitor with a > 1,000-fold selectivity for inhibition of calcium-independent PLA2 as compared to calcium-dependent PLA2 activity ( 14 hypoxia. Hypoxia also had no effect on the apparent substrate specificity (plasmalogen vs diacylglycerophospholipid) or calcium ion requirements for membrane-associated PLA2 activity. Thus, 20 min of hypoxia in proximal tubules is associated with a selective increase in cytosolic PLA2 activity that does not require calcium (i.e., calcium independent) and demonstrates a distinct preference for plasmalogen substrates (i.e., plasmalogen selective). As shown in Fig. 2 vation rate constant of 0.15 min-'). In preliminary experiments, we have found that incubation ofproximal tubule cytosolic subcellular fractions with a 1 -AM concentration of Compound I for 10 min at 370C results in > 95% inhibition of cytosolic calcium-independent, plasmalogen-selective PLA2 without having any significant effect on calcium-dependent PLA2 tested against diacylglycerophospholipid substrates (data not shown).
To determine if Compound I is able to diffuse across the proximal tubule cell membrane to gain access to the catalytic site of the cytosolic plasmalogen-selective, calcium-independent PLA2 to inhibit the enzyme in intact cells, we measured PLA2 activity in hypoxic proximal tubules pretreated with Compound I. As shown in Fig. 4 , pretreatment of the cells for 30 min with Compound I resulted in a dose-dependent inhibition of plasmalogen-selective, calcium-independent PLA2 in proximal tubules with maximal (60%) inhibition of the hyp- To determine whether inhibition of plasmalogen-selective, calcium-independent PLA2 with Compound I would prevent the loss of surface membrane integrity during hypoxia, we examined the effect of Compound I on the magnitude of 20-min hypoxia-induced LDH release (Fig 5) . In the absence ofCompound I, 20 min of hypoxia resulted in an increase in the release of LDH from 7.5% to 38% (n = 6), demonstrating that hypoxia-induced tubule cell damage in these experiments was similar to previously described changes in hypoxic tubules (4) . Pretreatment of proximal tubules with 10 jiM Compound I for 30 min resulted in a 55% reduction in the magnitude of hypoxia-induced LDH release.
To establish whether inhibition of plasmalogen-selective, calcium-independent PLA2 with Compound I, a maneuver that decreased cytotoxicity, was associated with decreased generation of free fatty acids, we examined the effect ofCompound I on the magnitude of hypoxia-induced AA release (Fig 6) . In the absence of Compound I, 20 min of hypoxia resulted in an increase in the release of arachidonic acid from 3±1 to 28±4 ng/mg protein, similar to previously described changes in hypoxic tubules (4) . Pretreatment ofproximal tubules with 10 jiM Compound I for 30 min resulted in a concentration-dependent reduction in the magnitude of hypoxia-induced AA release (n = 4). With 10 juM Compound I, AA release during hypoxia was reduced > 50%. These results and those described above are consistent with the conclusion that inhibition of cytosolic plasmalogen-selective PLA2 plays an important role in preventing both AA generation and LDH release during hypoxia by preserving the integrity of the cell surface membrane.
Discussion
The results ofthe present study are the first to demonstrate that the predominant PLA2 activity in proximal tubules is mediated by a protein (or proteins) with a unique preference for plasmalogen substrates. Our studies also suggest that the amount of PLA2 activity present in proximal tubules is likely to be underestimated in previous studies that used diacylglycerophospholipid substrates ( 1, 5 ) . The exclusive use of diacylglycerophospholipid substrates would also account for the failure to recognize the rapid activation of proximal tubule cytosolic PLA2 during hypoxia, since this observation could only be demonstrated with the use of plasmalogen substrates. The relative preference of PLA2 activity for plasmalogen substrates is not likely to be attributed entirely to differences in the physical state ofdiacyl vs plasmalogen substrates. For example, it can be demonstrated that calcium-independent, plasmalogen-selective PLA2 from the heart displays a distinct preference for plasmalogen substrates when both diacyl and plasmalogen substrates are presented to the enzyme as a mixture in the same bilayer lipid structure (i.e., the enzyme obeys strict surface-dilution kinetics in mixed plasmalogen-diacyl phospholipid substrate vesicles [121) . Thus, while differences in molecular conformation of plasmalogen and diacyl phospholipids may contribute to differences in PLA2-catalyzed hydrolytic rates, the relative preference of the enzyme for plasmalogen substrates may still be evident when both substrates are presented simultaneously to the enzyme in the same physical state. The PLA2 activity defined in proximal tubules with plasmalogen substrates was calcium-independent based on the observation that maximal activity was obtained in the presence of EGTA and that basal activity was not substantially affected by the presence of a high calcium ion concentration (10 mM). Calcium-independent PLA2 was present in both cytosolic and membrane fractions prepared from isolated proximal tubules with the majority of activity present in the cytosol, where the reaction velocity observed with choline plasmalogens was greater than that observed with choline diacylglycerophospholipid substrates. The cytosolic localization, expression ofmaximal activity in the presence of EGTA, and relative specificity for plasmalogen substrates are features very similar to those previously described for plasmalogen-selective PLA2 in canine myocardium (6) . However, in contrast to the canine myocardial enzyme, proximal tubule cytosolic plasmalogen-selective PLA2 is not inhibited by supraphysiologic calcium ion concentrations. In marked contrast to the previously described ischemia-stimulated, membrane-associated PLA2 from rabbit myocardium (13) , we found no changes in membrane-associated, plasmalogen-selective PLA2 after hypoxic injury to proximal tubules. Instead, there was a threefold increase in cytosolic plasmalogen-selective PLA2 after hypoxic injury to proximal tubules. Taken together, our data suggest that the proximal tubule and myocardial PLA2 proteins represent distinct members ofthe calcium-independent, plasmalogen-selective class ofintracellular PLA2 enzymes that could be regulated during hypoxia by different mechanisms. In preliminary studies using rabbit kidney cortex tissue as starting material to partially purify soluble calcium-independent PLA2, we have used DEAE ion exchange chromatography and have found that the fractions containing PLA2 enzyme activity using phosphatidylethanolamine substrates coelutes with PLA2 activity using choline plasmalogen substrate. SDS-PAGE of the active fractions shows a band at 40 kD that immunoreacts with the same pancreatic PLA2 antibody described previously in proximal tubules (4). Thus, the plasmalogen-selective PLA2 may represent the same protein that we described in our earlier study (4) . Additional studies are in progress to complete the purification of this novel enzyme activity.
The mechanisms responsible for the hypoxia-induced activation of calcium-independent plasmalogen selective PLA2 in rabbit proximal tubules are currently unknown. In the present study we can exclude a direct effect of Ca2" on catalytic activity, since maximal activity could be achieved in the presence of 4 mM EGTA, and that activity was not altered significantly in the presence of 10 mM Ca2". In addition, the increase in plasmalogen-selective PLA2 during hypoxia measured in the absence or presence of calcium was confined to the cytosolic compartment with minimal change in membrane-associated activity. Accordingly, there is no significant translocation of enzyme activity, a characteristic of the human monocytic and rat kidney PLA2 enzyme activity using diacylglycerophospholipid substrates (21) (22) (23) (24) (25) (26) (27) (28) . Although Ca2+ is not required for catalytic activity and calcium-dependent translocation does not occur, it is still possible that calcium-dependent mechanisms such as protein kinase C-mediated phosphorylation of PLA2 may play a role in the activation of cytosolic plasmalogen-selective PLA2 in rabbit proximal tubules during hypoxia. Other potential mechanisms which may participate in the modulation ofcalcium-independent plasmalogen selective PLA2 activity include phosphorylation by tyrosine-kinases (23, 24) , interactions with G protein alpha subunits (29) and beta gamma heterodimers (30), synthesis of inhibitory or activating proteins (31, 32) , and alterations in transcriptional regulation of PLA2 genes (33) . Further studies are required to define which of these mechanisms may participate in the upregulation of calcium-independent, plasmalogen-selective PLA2 during hypoxia in rabbit proximal tubules.
Several lines of evidence suggest that the PLA2 activity previously defined in proximal tubules using choline diacylglycerophospholipids, which is not activated during hypoxia, represents a distinct PLA2 enzyme. Specifically, the cytosolic enzyme previously characterized in rat kidney (27) using diacylglycerophospholipid substrates requires calcium concentrations > 100 nM to be activated, and its activity increases with increased calcium concentrations. In contrast, the proximal tubule plasmalogen selective PLA2 activity described in our studies can be demonstrated in the presence of 4 mM EGTA, and its activity is not increased by increased calcium concentrations.
The increase in cytosolic plasmalogen-selective PLA2 during hypoxia precedes the accumulation of unesterified arachidonic acid previously observed during hypoxia in proximal tubules (4) . Plasmalogens in many tissues, including isolated proximal tubules, are known to have a high content of arachidonic acid esterified at the sn-2 position (34, 35) . Thus, the activation of a proximal tubule PLA2 enzyme with a distinct preference for plasmalogen substrates may represent an important event in the generation of unesterified arachidonic acid and of biologically active eicosanoid derivatives previously observed during hypoxia in the kidney (2-4). Indeed, cytosolic proximal tubule plasmalogen-selective PLA2 has several features that suggest that this enzyme activity plays a potentially important role in the pathogenesis of membrane injury during hypoxia. First, our preliminary studies demonstrate that plasmalogen molecular species comprise a significant fraction of proximal tubule phospholipids (35) . Second, hypoxia in isolated proximal tubules in vitro results in the rapid and selective activation ofcytosolic plasmalogen-selective, calcium-independent PLA2. Third, activation of this PLA2 activity occurs very rapidly before there is evidence of irreversible injury to the cell surface membrane based on measurements of LDH release.
The activation of a cytosolic enzyme during hypoxia is likely to affect not only plasma membranes, but also membranes of other intracellular organelles containing plasmalogen phospholipids. Thus, accelerated phospholipolysis initiated by cytosolic calcium-independent PLA2 activation during hypoxia could ultimately contribute to cell death.
The effect of inhibition of plasmalogen-selective, calciumindependent PLA2 on hypoxia-induced cell death has not been previously examined in any tissue. Inhibition of proximal tubule cytosolic plasmalogen-selective, calcium-independent PLA2 with Compound I is accompanied by a substantial reduction in both AA generation and total LDH release, as well as a delay in the time course of LDH release during hypoxia. This supports the conclusion that the activation ofcytosolic plasmalogen-selective PLA2 during hypoxia plays an important role in the processes responsible for generation of free fatty acids and loss of surface membrane integrity and cytosolic LDH release. Our direct demonstration that Compound I prevents the hypoxia-induced selective increase in proximal tubule plasmalogen-selective PLA2, reduces production of free AA during hypoxia, and is accompanied by preservation of the permeability barrier function of the surface membrane is compelling evidence to suggest that accelerated hydrolysis of membrane plasmalogens may contribute to the development of membrane injury during hypoxia in proximal tubules. Further studies are needed to fully define the role of endogenous proximal tubule plasmalogens as substrates for calcium-independent, plasmalogen-selective PLA2, and to determine whether activation of this enzyme activity accompanied by decreased phospholipid mass, increased production of unesterified fatty acids, or accumulation of lysoplasmalogen products may contribute to the pathogenesis of hypoxic cell injury in proximal tubules.
